Kashishian A, Cooper J A
Fred Hutchinson Cancer Research Center, Seattle, Washington 98104.
Mol Biol Cell. 1993 Jan;4(1):49-57. doi: 10.1091/mbc.4.1.49.
We have identified two tyrosine phosphorylation sites, Tyr 1009 and Tyr 1021, in the C-terminal noncatalytic region of the human platelet-derived growth factor (PDGF) receptor beta subunit. Mutant receptors with phenylalanine substitutions at either or both of these tyrosines were expressed in dog epithelial cells. Mutation of Tyr 1021 markedly reduced the PDGF-stimulated binding of phospholipase C (PLC) gamma 1 but had no effect on binding of the GTPase activator protein of Ras or of phosphatidylinositol 3 kinase. Mutation of Tyr 1009 reduced binding of PLC gamma 1 less severely. Mutation of Tyr 1021, or both Tyr 1009 and Tyr 1021, also reduced the PDGF-dependent binding of a transiently expressed fusion protein containing the two Src-homology 2 domains from PLC gamma 1. Mutation of Tyr 1021, or both Tyr 1009 and Tyr 1021, greatly reduced PDGF-stimulated tyrosine phosphorylation of PLC gamma 1 but did not prevent the tyrosine phosphorylation of other cell proteins, including mitogen-activated protein kinase. We conclude that Tyr 1021, and possibly Tyr 1009, is a binding site for PLC gamma 1.
我们已经在人血小板衍生生长因子(PDGF)受体β亚基的C末端非催化区域鉴定出两个酪氨酸磷酸化位点,即Tyr 1009和Tyr 1021。在这两个酪氨酸位点之一或两者处被苯丙氨酸取代的突变受体在犬上皮细胞中表达。Tyr 1021的突变显著降低了PDGF刺激的磷脂酶C(PLC)γ1的结合,但对Ras的GTP酶激活蛋白或磷脂酰肌醇3激酶的结合没有影响。Tyr 1009的突变对PLCγ1结合的降低程度较小。Tyr 1021或Tyr 1009和Tyr 1021两者的突变也降低了包含来自PLCγ1的两个Src同源2结构域的瞬时表达融合蛋白的PDGF依赖性结合。Tyr 1021或Tyr 1009和Tyr 1021两者的突变极大地降低了PDGF刺激的PLCγ1的酪氨酸磷酸化,但并未阻止其他细胞蛋白的酪氨酸磷酸化,包括丝裂原活化蛋白激酶。我们得出结论,Tyr 1021,可能还有Tyr 1009,是PLCγ1的结合位点。